Leap Therapeutics’ $40 Million Private Placement

Paul Hastings LLP advised J.P. Morgan Securities LLC as the exclusive placement agent in the transaction.Leap Therapeutics, Inc. (Nasdaq:LPTX) has entered into a securities purchase agreement with a…

This content is for Standard 1 Year members only.
Login Join Now
Laura Testa

Author: Laura Testa

This content is for Standard 1 Year members only.
Login Join Now